(Q44950241)

7 December 2017

title

Effects of 1-year intermittent treatment with topical tacrolimus monotherapy on skin collagen synthesis in patients with atopic dermatitis (English)

1 reference

7 December 2017

Kyllönen H

1

1 reference

7 December 2017

Remitz A

2

1 reference

7 December 2017

Mandelin JM

3

1 reference

7 December 2017

Elg P

4

1 reference

7 December 2017

Reitamo S

5

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 June 2004

1 reference

British Journal of Dermatology

7 December 2017

published in

1 reference

7 December 2017

volume

150

1 reference

7 December 2017

issue

6

1 reference

7 December 2017

page(s)

1174-1181

1 reference

A new method to measure type I and III collagen synthesis in human skin in vivo: demonstration of decreased collagen synthesis after topical glucocorticoid treatment.

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.06017.X

Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.06017.X

Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.06017.X

The influence of female sex hormones on skin thickness: evaluation using 20 MHz sonography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.06017.X

Influence of body water distribution on skin thickness: measurements using high-frequency ultrasound.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.06017.X

FK506, an immunosuppressant targeting calcineurin function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.06017.X

Tacrolimus induces increased expression of transforming growth factor-beta1 in mammalian lymphoid as well as nonlymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.06017.X

The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.06017.X

Collagen: Structure, function, and metabolism in normal and fibrotic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.06017.X

Increased content of type III collagen at the rupture site of human Achilles tendon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.06017.X

Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.06017.X

A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.06017.X

Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.06017.X

A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.06017.X

Characterization of the Interaction of FKBP12 with the Transforming Growth Factor-β Type I Receptorin Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2004.06017.X

10.1111/J.1365-2133.2004.06017.X

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference